G6PD deficient cells and the bioreduction of disulfides: Effects of DHEA, GSH depletion and phenylarsine oxide

被引:31
作者
Biaglow, JE [1 ]
Ayene, IS [1 ]
Koch, CJ [1 ]
Donahue, J [1 ]
Stamato, TD [1 ]
Tuttle, SW [1 ]
机构
[1] Univ Penn, Sch Med, Dept Radiat Oncol & Biophys, Philadelphia, PA 19104 USA
关键词
D O I
10.1006/bbrc.2000.3024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We used Glucose 6 phosphate dehydrogenase (G6PD) minus cells (89 cells) and G6PD containing cells (KI) to understand the mechanisms of bioreduction of disulfide and the redox regulation of protein and non protein thiols in mammalian cells. The 89 cells reduce hydroxyethyldisulfide (HEDS) to mercaptoethanol (ME) at a slower rate than K1 cells. HEDS reduction results in loss of nonprotein thiols (NPSH) and a decrease in protein thiols (PSH) in 89 cells. The effects are less dramatic with K1 cells, However, the loss of NPSH and PSH in K1 cells are increased in the absence of glucose. Glutathione-depletion with L-BSO partially blocks HEDS reduction in K1 and 89 cells. Treatment with the vicinal thiol reagent phenyl arsenic oxide (PAO) blocks reduction of HEDS in both cells. Surprisingly, dehydroepiandrosterone (DHEA), a known inhibitor of G6PD, inhibits the growth and blocks the reduction of HEDS both in 89 and K1 cells suggesting that its mechanism for inhibition of growth is not G6PD related. (C) 2000 academic Press.
引用
收藏
页码:846 / 852
页数:7
相关论文
共 36 条
  • [1] AYENE IS, 2000, UNPUB INT J RAD BIOL
  • [2] Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression
    Banki, K
    Hutter, E
    Colombo, E
    Gonchoroff, NJ
    Perl, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) : 32994 - 33001
  • [3] NON-PROTEIN THIOLS AND THE RADIATION RESPONSE OF A549 HUMAN-LUNG CARCINOMA-CELLS
    BIAGLOW, JE
    CLARK, EP
    EPP, ER
    MORSEGUADIO, M
    VARNES, ME
    MITCHELL, JB
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1983, 44 (05) : 489 - 495
  • [4] USE OF OXIDANT DIAMIDE FOR STUDYING NONMITOCHONDRIAL REDUCING CAPACITY OF EHRLICH ASCITES TUMOR-CELLS
    BIAGLOW, JE
    NYGAARD, OF
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1973, 54 (03) : 874 - 881
  • [5] BIAGLOW JE, 2000, UNPUB RAD RES
  • [6] BIAGLOW JE, 2000, IN PRESS ANAL BIOCH
  • [7] BIAGLOW JE, 2000, IN PRESS ADV EXPT ME
  • [8] BJORNSTEDT M, 1995, METHOD ENZYMOL, V252, P209
  • [9] Boros LG, 1997, CANCER RES, V57, P4242
  • [10] Dashtaki R, 1998, J PHARMACOL EXP THER, V285, P876